Madeline Bell, President and CEO of Children’s Hospital of Philadelphia (CHOP), left, and Christopher Gheysens, Chairman, CHOP Board of Trustees | LinkedIn
Madeline Bell, President and CEO of Children’s Hospital of Philadelphia (CHOP), left, and Christopher Gheysens, Chairman, CHOP Board of Trustees | LinkedIn
The Children’s Hospital of Philadelphia (CHOP) was among the “12 worst offending children’s hospitals promoting sex change treatments for minors,” performing such experimentation on 122 patients between 2019 and 2023.
That’s according to a national database released today of hospitals and medical facilities “administering irreversible sex change interventions on children in the United States” by the organization Do No Harm.
“With the launch of the Stop the Harm Database, Do No Harm is building on our mission to expose the dangers of experimental pediatric gender medicine and bring the practice to an end,” said Do No Harm Chairman Dr. Stanley Goldfarb, in a press release. “This first-of-its-kind project provides patients, families, and policymakers with a resource that reveals the pervasiveness of irreversible sex-change treatments for minors in America.
“While this data represents the tip of the iceberg, this is the first step in holding the medical establishment accountable for participating in, and often times promoting, predatory and unscientific medical interventions for vulnerable children,” Goldfarb said.
Do No Harm said the database “catalogs pediatric sex change-related services, including surgeries, cross-sex hormones, and puberty blockers, at U.S.-based medical facilities between 2019 and 2023.”
The data represents sources including “claims clearinghouses, data aggregators, payors, health systems, CMS, and multiple open data sources,” according to Do No Harm, and includes data from commercial insurance, Medicaid, Medicare, and VA claims.”
CHOP saw 122 “sex change” patients, who were children, from 2019 to 2023, according to the database, including 5 surgery patients and 117 total “hormone and puberty blocker” patients. There were 768 total prescriptions written. In all, it amounted to $230,784 total submitted charges.
Founded in 1855, CHOP is the nation's first hospital dedicated to pediatric care. It is a nonprofit institution that provides a range of medical services, including primary care, specialty care, and research. The hospital is affiliated with the University of Pennsylvania and operates several satellite locations throughout the Philadelphia region.
Madeline Bell, a former pediatric nurse who has worked in various roles within CHOP since 1983, is the hospital's president and CEO. Bell is on the board of Comcast-NBCUniversal, as well as the Leonard Davis Institute of Health Economics, accordingn to CHOP's website. She also is on the executive committee of the Chamber of Commerce for Greater Philadelphia.
The chairman of CHOP's board of trustees is Christopher Gheysens, the CEO of Wawa, Inc. A 1989 graduate of Villanova University, a Catholic institution founded by the Order of St. Augustine, Gheysens is also a member of the university's Board of Trustees and former chair of the Dean's Advisory Council for the Villanova School of Business.
CHOP has operated the “Gender & Sexuality Development Clinic” since 2014. The clinic "offers medical care and mental health support for gender nonconforming, gender expansive and transgender children and youth up to age 21 and their families," according to the CHOP website.
UPMC Children’s Hospital of Pittsburgh (UPMC) was the only other Pennsylvania hospital to make the group’s “Dirty Dozen” list, seeing 28 “sex change patients,” including 4 surgery patients and 24 total “hormone and puberty blocker patients.” There were 123 total prescriptions written at UPMC, with $5,850 in total charges.
In all, hospitals in Pa. saw 822 minors who were “sex change patients,” including 316 total surgery patients. These Pa. hospitals administered “hormone and puberty blockers” to 518 total children, and wrote 3,469 prescriptions. In all, it totalled $6,032,103 in total submitted charges.
Chloe Cole, a senior fellow at Do No Harm, said the database “proves the lies from the medical establishment and radical politicians who argue that cases like mine are rare.”
A 20-year-old woman who said that she had “gender dysphoria” was given “puberty blockers,” testosterone and had a double mastectomy at age 12, Cole has since “de-transitioned” and supports bans on the chemical castration of minors.
“The stats in this database represent thousands of kids who are being treated like Guinea pigs for unproven, and sometimes dangerous, medical experiments,” said Cole. “I hope politicians and parents alike use this database to see where these treatments are happening and protect their children from being rushed into irreversible, life-altering treatments.”
Nationally, 13,994 children received sex change related treatments between 2019 and 2023, according to Do No Harm’s database. This includes 5,747 sex change surgeries performed on children, and 62,682 hormone and puberty blockers prescriptions written for 8,579 pediatric patients.
“At least $119,791,202 made from sex change treatments performed on minors,” reported the organization.
The "Dirty Dozen" Hospitals
The “12 worst offending children’s hospitals promoting sex change treatments for minors" according to Do No Harm.
Alerts Sign-up